Connect with us

Hi, what are you looking for?

Jewish Business News

VC, Investments

American Yorkville to invest $10 million in Israeli Insuline

INSULINE
Insuline product

InsuLine Medical Ltd. (TASE: INSL) has signed an investment agreement with Yorkville Advosers LLC for up to $10 million using the REPA mechanism. Insuline develops, produces and markets technologies and products for improve the effectiveness of the insulin injected into diabetes patients.

REPA allows ongoing financing in exchange for shares at a pre-agreed price thus not creating pressure on the share price.

INSULINE

 –

Insuline CEO Ron Nagar said, “The investment agreement we have signed allows the company financing flexibility for its business needs ahead of its rapid entry into Germany and due to its non-binding memorandum of understanding with Johnson & Johnson to distribute the InsuPad device.”
Published by www.globes-online.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Advertisement
cialis